Molnupiravir is an experimental antiviral drug which is orally active and was developed for the treatment of influenza. It is a prodrug of the synthetic nucleoside derivative N4-hydroxycytidine, and exerts its antiviral action through introduction of copying errors during viral RNA replication.
- Generic Name: molnupiravir
- Brand Name: Lagevrio
What is Lagevrio and how is it used?
Lagevrio is a prescription medicine used to treat the symptoms of COVID-19. Lagevrio may be used alone or with other medications.
Lagevrio belongs to a class of drugs called Antivirals, SARS-CoV-2.
It is not known if Lagevrio is safe and effective in children.
What are the possible side effects of Lagevrio?
Lagevrio may cause serious side effects including:
- difficulty breathing,
- swelling of your face, lips, tongue, or throat,
Get medical help right away, if you have any of the symptoms listed above.
The most common side effects of Lagevrio include:
- nausea, and